Tag: Alzheimer’s
Early-Onset Alzheimer Disease Patients in Rural Areas Lack Specialty Care
Rural patients more likely to be diagnosed and treated by primary care providers
Rapid Olfactory Decline May Predict Later Cognitive Impairment in Seniors
Rapid olfactory decline also associated with smaller gray matter volumes on MRI in olfactory- and memory-associated brain regions
Effect of Noradrenergic Drugs Explored in Alzheimer Disease
Meta-analyses suggest positive effects of noradrenergic drugs on global cognition, apathy
Changes in Alzheimer Biomarkers Tied to Withdrawal of PAP for OSA
Increase in neurofilament light, decrease in Aβ40 associated with withdrawal of positive airway pressure for obstructive sleep apnea
Reduction in Vial Size of Aducanumab Could Yield Savings
Savings would range from $70.9 to $369.0 million annually if the 300 mg/3.0 mL vial was reduced to 100 mg/1.0 mL
Financial Altruism May Indicate Cognitive Decline in Seniors
Financial altruism negatively associated with performance on cognitive measures known to be sensitive to early Alzheimer disease
Prevalence of LATE-NC Explored in Seniors, Alzheimer Disease
Almost 40 percent of those with ADNC had limbic-predominant age-related TDP-43 encephalopathy neuropathologic change
New Alzheimer Disease Drug Delivers Disappointing Results
Trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition
Medicare Spending Spikes for Dementia Diagnoses in Seniors
Medicare spending higher for adults with a formal clinical diagnosis of dementia versus a positive screening for cognitive impairment
Prevalence of Risk Factors for Alzheimer, Related Dementias Identified
Highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity